Euglycemic Diabetic Ketoacidosis Related to SGLT2 Inhibitor Use in a Patient With Cobalamin C Deficiency and Diabetes

A 24-year-old woman with cobalamin C deficiency (CblCD), autoimmune thyroiditis, and recently diagnosed diabetes mellitus presented with weight loss, emesis, and abdominal pain. She had been placed on sodium-glucose cotransporter inhibitor (SGLT2i) therapy because of metformin intolerance, with the...

Full description

Saved in:
Bibliographic Details
Main Authors: Camilia Kamoun, Jaclyn Tamaroff, Sanmati Cuddapah, Marc Yudkoff, Shana McCormack, Jessica I. Gold
Format: Article
Language:English
Published: American College of Physicians 2023-01-01
Series:Annals of Internal Medicine: Clinical Cases
Online Access:https://www.acpjournals.org/doi/10.7326/aimcc.2022.0346
Tags: Add Tag
No Tags, Be the first to tag this record!